BridgeMD
Tests treatment safety and results for ADHD
Official title Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity
ClinicalTrials.gov ID: NCT06797726
What this study is testing
- What it's testing
- The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of the 12-week retention rate of patients randomised to CBT compared with patients in the 'treatment as usual' control arm. In order to meet the objective, the patient will take part in a standardized assessment, followed by a therapeutic intervention and a new standardized assessment after the intervention.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 (age ≥ 18 years)
- Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity
- Patient affiliated to a social security scheme
- For patients treated with methylphenidate: no change in treatment dosage during the previous three months.
- For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months.
You likely can't join if
- Patients with psychotic disorders (assessed by clinician)
- Pregnant or breast-feeding women
- Patients under protective supervision (guardianship or curatorship)
- Persons under court protection
- Persons deprived of their liberty
- Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment).
See the full eligibility criteria
- Patient over 18 (age ≥ 18 years)
- Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity
- Patient affiliated to a social security scheme
- For patients treated with methylphenidate: no change in treatment dosage during the previous three months.
- For patients not treated with methylphenidate: no introduction of methylphenidate within the next three months.
- Patients with psychotic disorders (assessed by clinician)
- Pregnant or breast-feeding women
- Patients under protective supervision (guardianship or curatorship)
- Persons under court protection
- Persons deprived of their liberty
- Patients who do not meet the eligibility criteria for CBT (e.g., cognitive impairment, hearing impairment).
- Physical inability to participate in CBT sessions (e.g., lack of telephone, foreseeable unavailability).
- Difficulty understanding self-questionnaires, including illiteracy.
- Participation in another treatment research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome.
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
- Nantes, France
- Tours, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France; Nantes, France; Tours, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.